Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0000905718-22-000484

Options or other derivatives

  • 10% owner acquired 78,045 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Abingworth LLP · 10% owner

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-21 Grant or award : show line 1 in the form Stock Option (right to buy) +78,045 78,045 I
Loading xslF345X03/jasper_fm4mar212022.xml…